8-bromo cyclic adenosine monophosphate has been researched along with Hypertrophy in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Scholz, PM; Weiss, HR; Yan, L; Zhang, Q | 1 |
Kano, H; Kohno, M; Minami, M; Yasunari, K; Yokokawa, K; Yoshikawa, J | 1 |
2 other study(ies) available for 8-bromo cyclic adenosine monophosphate and Hypertrophy
Article | Year |
---|---|
Cyclic GMP protein kinase activity is reduced in thyroxine-induced hypertrophic cardiac myocytes.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Body Weight; Cyclic AMP; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Drug Administration Schedule; Drug Synergism; gamma-Aminobutyric Acid; Guanosine; Heart Ventricles; Hypertrophy; Injections, Intramuscular; Myocardial Contraction; Myocytes, Cardiac; Organ Size; Oxygen Consumption; Phosphoproteins; Phosphorylation; Rabbits; Stimulation, Chemical; Thyroxine; Time Factors | 2003 |
Dopamine D1-like receptor stimulation inhibits hypertrophy induced by platelet-derived growth factor in cultured rat renal vascular smooth muscle cells.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; 8-Bromo Cyclic Adenosine Monophosphate; Animals; Becaplermin; Benzazepines; Cells, Cultured; Colforsin; Dopamine Antagonists; Hypertrophy; Isoquinolines; Muscle, Smooth, Vascular; Platelet-Derived Growth Factor; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-sis; Rats; Receptors, Dopamine D1; Renal Artery; Sulfonamides; Tetrahydroisoquinolines | 1997 |